Pfizer pushes fourth dose of extremely profitable COVID shot
(NaturalHealth365) Ever looked at an official U.S. Centers for Disease Control and Prevention (CDC) COVID vaccination record card? You’ll notice that the card has four spaces for documenting doses – and has had four lines since the beginning. Two lines are for documenting the “1st” and “2nd” COVID jab doses. An additional two lines are simply labeled “Other.”
Skeptics have to wonder: isn’t that just too convenient? We now know that pharmaceutical giant and COVID shot producer Pfizer is currently pushing for dose 4 of its highly profitable gene therapy drug.
Dose 4 on the way: Pfizer fervently seeking authorization for next dose of their highly profitable COVID shot
On Face the Nation last week, Pfizer CEO Albert Bourla assured viewers that his company is working “very diligently” to create a COVID shot that will offer safe and effective protection against SARS-CoV-2 and its variants “for at least a year.”
In the meantime, however, expect a fourth dose coming your way.
Pfizer is reportedly in the process of seeking authorization from the U.S. Food and Drug Administration (FDA) for dose 4 of its mRNA COVID poke for all Americans age 65 and up.
Of course, four doses aren’t unheard of. According to the CDC, anyone in the U.S. who is over the age of 12 and moderately or severely immunocompromised should have already received a fourth COVID shot – a shot of what Bloomberg Business calls “one of the best-selling medicines of all time” (emphasis ours).
In case you were wondering, the CDC defines “moderately or severely immunocompromised” as anyone who is actively receiving cancer treatment, taking medications to suppress the immune system, or taking high-dose steroids, as well as anyone who has received an organ transplant or stem cell transplant, or has advanced or untreated HIV infection or immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome).
How’s this for following the money: In 2021, Big Pharma earned more in one minute than most Americans earn in an entire YEAR
An organization called the Peoples Vaccine Alliance recently revealed some shocking insights into just how profitable these mRNA gene therapy drugs have truly been for Pfizer and Moderna.
As noted on Relief Web, a webpage associated with the United Nations Office for the Coordination of Humanitarian Affairs, the two Pharma bigwigs earned a combined $34 billion in 2021. (This could even be a gross underestimation, as Bloomberg Business noted in July 2021 that Pfizer alone was projecting a $33.5 billion COVID shot profit.)
As a conservative estimate, this rate of profit translates to:
- $93.5 million per day
- $65,000 a minute
- $1,000 a second
Yup – the average American’s annual income earned by just two of the world’s Pharma companies in less time than it takes for Albert Bourla to brush his teeth in the morning.
It is truly difficult to wrap one’s head around the sheer vastness of these drug companies’ wealth … and a lot less difficult to imagine why they are so insistent on getting more people to take even more COVID shots.
Sources for this article include:
PBS.org
Childrenshealthdefense.org
Washingtonpost.com
Bloomberg.com
Reliefweb.int
Ziprecruiter.com